Conditions We Treat with Regenerative Medicine in Cancún

Mesenchymal stem cell (MSC) therapy and PRP are among the most studied regenerative options for knee osteoarthritis. Peer-reviewed trials report improvements in pain, function and cartilage signal on MRI in selected patients. Candidacy depends on the grade of osteoarthritis (Kellgren-Lawrence I-III tend to respond best), age, weight and overall joint health — all assessed during a medical evaluation.

For some patients with moderate osteoarthritis, regenerative protocols may delay or postpone the need for joint replacement. For advanced (grade IV) osteoarthritis with bone-on-bone changes, surgery often remains the definitive treatment and we will tell you so honestly during your consultation.

Most patients report meaningful improvements in pain and mobility between weeks 4 and 12 after the procedure, with cumulative benefits often peaking at 3 to 6 months. Combining the intra-articular application with movement therapy and metabolic optimization improves and sustains results.

Yes. We offer dedicated spine protocols for disc degeneration, facet pain and chronic mechanical low back pain. Treatment combines regenerative injections, guided rehabilitation and lifestyle modifications. Severe cases with neurological compromise are referred to surgical evaluation first.

Fibromyalgia is associated with chronic neuroinflammation and central sensitization. Mesenchymal stem cells have documented immunomodulatory and anti-inflammatory effects, and small clinical studies report improvements in pain, fatigue and sleep quality. We use it as supportive care, never as a replacement for your rheumatologist.

Peripheral neuropathy (often from diabetes, chemotherapy or autoimmune origin) may respond to MSC therapy combined with metabolic support and IV therapy. Goals include reducing burning pain, improving sensation and slowing progression. Realistic expectations are discussed during evaluation.

Research is ongoing and we apply MSC therapy strictly as an adjunct to standard neurorehabilitation, never as a cure. The goal is to reduce neuroinflammation and support neuroplasticity during the recovery window.

Mesenchymal stem cell therapy has been studied as supportive treatment for type 2 diabetes, with several trials reporting improvements in HbA1c, insulin sensitivity and pancreatic function. It is adjunctive — not a replacement for medication, nutrition or exercise — and works best inside an integral metabolic plan.

Targeted IV protocols (NAD+, vitamins, antioxidants and minerals) address nutritional deficits and oxidative stress that often accompany chronic fatigue and metabolic syndrome. Combined with regenerative protocols and lifestyle changes, patients report higher energy and better tolerance to exercise.

Yes — at least initially. Any change in chronic medication must be coordinated with your treating physician. Our role is to optimize your metabolic terrain so that, in some cases, your endocrinologist can safely reduce or adjust doses over time.

Systemic lupus erythematosus and rheumatoid arthritis are autoimmune conditions where MSC therapy has been investigated for its immunomodulatory effect. Published trials report reductions in disease activity scores and steroid requirements in selected patients. We work alongside your rheumatologist — never in replacement of biologics or DMARDs.

In most cases yes, but timing and protocol must be coordinated carefully. We review every patient's current medication, blood work and disease activity before recommending a session. If your condition is in an active flare, we typically wait until it is stabilized.

These conditions share an underlying autoimmune and inflammatory pattern. MSC and exosome therapies are studied as supportive treatment to rebalance the immune response. Results vary; expectations are set honestly during your medical evaluation.

Several published studies and meta-analyses have evaluated intravenous MSC therapy for post-COVID respiratory and inflammatory sequelae, with reports of improved oxygenation, fatigue and quality of life. We use it as adjunctive care alongside pulmonary rehabilitation.

We offer supportive protocols for chronic bronchitis and selected cases of pulmonary fibrosis. Advanced fibrosis with significant oxygen requirement is usually outside our scope and we will tell you so directly.

We address skin aging, loss of elasticity, collagen and facial volume loss, hair thinning and cellular senescence with stem cell, exosome and PRP protocols, combined with NAD+ IV therapy. The goal is healthy aging, not cosmetic perfection.

PRP and exosome-based protocols stimulate the hair follicle's regenerative environment, supporting hair density and quality in androgenetic alopecia and hair thinning. Best results are seen when combined with medical evaluation of hormones, nutrition and scalp health.

Yes. We offer dedicated sexual-wellness protocols using PRP, peptides and regenerative injections to support erectile function, vaginal health and libido. As always, results vary and we evaluate hormonal and vascular health first.